ABBOTINDIAPharmaceuticals
Abbott India Ltd — PE Ratio & Valuation Analysis
₹25915.00
-1.02%
Current P/E41.99xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E51.0x17.7% below avg
⚠️
32.2% Premium to Industry
ABBOTINDIA P/E 41.99x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹665.62 | ₹29025 | 43.6x |
| 2024 | ₹565.28 | ₹29741 | 52.6x |
| 2023 | ₹446.78 | ₹22851 | 51.1x |
| 2022 | ₹375.86 | ₹21367 | 56.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Abbott India Ltd Valuation
Abbott India Ltd (ABBOTINDIA) currently trades at 41.99x earnings. The Pharmaceuticals sector average PE is 31.77x. ABBOTINDIA commands a premium, reflecting high growth expectations. Historically, ABBOTINDIA has traded at an average PE of 51.0x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
35.68%
Dividend Yield
1.59%
More on Abbott India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.